Search form
Search
EN
IT
MyPage
Staff Webmail
Student Webmail
Address book
Center for
Advanced Studies
and Technology
About us
CRC
Diagnostics
Facilities
Research Groups
Research Biobanks
Location
Home
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
12 June 2020
An interesting work from Gianluca Sala
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
News
